Clinical Trial Update: Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immunogenicity of HBAI20 Hepatitis B Vaccine in naive adults and non-responders; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBAI20 Hepatitis B Vaccine (HBAI20 Hepatitis B Vaccine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED | Results posted: 2018-11-29